26 May 2020 argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis Member news
21 May 2020 Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib Member news
20 May 2020 Mithra and Searchlight Pharma announce filing of new drug submission for Estelle® in Canada Member news
08 May 2020 Progressing clinical development of next generation therapies for Diabetic eye disease – beyond anti-VEGF Member news
07 May 2020 Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals Member news
06 May 2020 Imec en Roswell Biotechnologies ontwikkelen biosensorchip voor het snel opsporen van infectieziekten en voor goedkoop uitlezen van DNA Member news
03 Mar 2020 Mithra Receives acceptance of Marketing Authorization Application (MAA) to market Estelle® in Belgium and Luxembourg Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us